New aprepitant suspension for use in children

Emend (aprepitant) is now available as a powder for oral suspension, allowing use of the neurokinin NK1 antagonist in children aged 6 months and over.

Licensed for the prevention of nausea and vomiting associated with highly and moderately emetogenic chemotherapy, the oral suspension can be prescribed for children aged 6 months to 11 years weighing at least 6kg. The recommended dose is based on body weight and should be administered one hour before chemotherapy on days 1, 2 and 3 or in the morning on days 2 and 3 if no chemotherapy is being given.

The oral suspension is supplied as 125mg powder in a sachet to provide a 125mg/5ml oral suspension after reconstitution. Emend capsules containing 80mg or 125mg aprepitant remain available for adults and adolescents.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases